Supplementary Tables 1 - 4 from Identification of Campath-1 (CD52) As Novel Drug Target in Neoplastic Stem Cells in 5Q-Patients with MDS and AML

Katharina Blatt,Harald Herrmann,Gregor Hoermann,Michael Willmann,Sabine Cerny-Reiterer,Irina Sadovnik,Susanne Herndlhofer,Berthold Streubel,Werner Rabitsch,Wolfgang R. Sperr,Matthias Mayerhofer,Thomas Rülicke,Peter Valent

crossref（2023）

Cited 0|Views0

No score

Abstract

PDF file - 85K, Supplementary Table S1: Characteristics of patients with MDS Supplementary Table S2: Characteristics of patients with AML Supplementary Table S3: Characteristics of patients with CML, CMML, MPS, AUL, and ALL Supplementary Table S4: Characteristics of patients with ICUS, normal/reactive bone marrow and long-term complete remission.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined